CN109601680A - 一种维护关节和缔结组织健康的雨生红球藻虾青素压片糖果及其制备方法 - Google Patents
一种维护关节和缔结组织健康的雨生红球藻虾青素压片糖果及其制备方法 Download PDFInfo
- Publication number
- CN109601680A CN109601680A CN201910045882.6A CN201910045882A CN109601680A CN 109601680 A CN109601680 A CN 109601680A CN 201910045882 A CN201910045882 A CN 201910045882A CN 109601680 A CN109601680 A CN 109601680A
- Authority
- CN
- China
- Prior art keywords
- astaxanthin
- vitamin
- joint
- pressed candy
- haematococcus pluvialis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 title claims abstract description 68
- 235000013793 astaxanthin Nutrition 0.000 title claims abstract description 68
- 239000001168 astaxanthin Substances 0.000 title claims abstract description 68
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 title claims abstract description 68
- 229940022405 astaxanthin Drugs 0.000 title claims abstract description 68
- 235000009508 confectionery Nutrition 0.000 title claims abstract description 45
- 241000168517 Haematococcus lacustris Species 0.000 title claims abstract description 30
- 230000036541 health Effects 0.000 title claims abstract description 24
- 210000002808 connective tissue Anatomy 0.000 title claims abstract description 21
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 238000012423 maintenance Methods 0.000 title description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 52
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 40
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 40
- 235000008434 ginseng Nutrition 0.000 claims abstract description 40
- 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 claims abstract description 28
- 235000020243 first infant milk formula Nutrition 0.000 claims abstract description 28
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 26
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 26
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 26
- 239000011718 vitamin C Substances 0.000 claims abstract description 26
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 claims abstract description 23
- 229930003316 Vitamin D Natural products 0.000 claims abstract description 23
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims abstract description 23
- 239000000905 isomalt Substances 0.000 claims abstract description 23
- 235000010439 isomalt Nutrition 0.000 claims abstract description 23
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 claims abstract description 23
- 235000019166 vitamin D Nutrition 0.000 claims abstract description 23
- 239000011710 vitamin D Substances 0.000 claims abstract description 23
- 150000003710 vitamin D derivatives Chemical class 0.000 claims abstract description 23
- 229940046008 vitamin d Drugs 0.000 claims abstract description 23
- 239000002994 raw material Substances 0.000 claims abstract description 22
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims abstract description 21
- 229940016286 microcrystalline cellulose Drugs 0.000 claims abstract description 21
- 239000008108 microcrystalline cellulose Substances 0.000 claims abstract description 21
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims abstract description 20
- 210000005067 joint tissue Anatomy 0.000 claims abstract description 18
- 241000208340 Araliaceae Species 0.000 claims abstract 7
- 239000000843 powder Substances 0.000 claims description 30
- 239000000203 mixture Substances 0.000 claims description 28
- 239000004365 Protease Substances 0.000 claims description 16
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 claims description 16
- 235000013399 edible fruits Nutrition 0.000 claims description 16
- 239000004615 ingredient Substances 0.000 claims description 15
- 239000002260 anti-inflammatory agent Substances 0.000 claims description 14
- 239000000463 material Substances 0.000 claims description 14
- 229940121363 anti-inflammatory agent Drugs 0.000 claims description 13
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 12
- 238000004806 packaging method and process Methods 0.000 claims description 12
- 230000001954 sterilising effect Effects 0.000 claims description 12
- 108010004032 Bromelains Proteins 0.000 claims description 8
- 240000000950 Hippophae rhamnoides Species 0.000 claims description 8
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims description 8
- 108090000526 Papain Proteins 0.000 claims description 8
- 235000019835 bromelain Nutrition 0.000 claims description 8
- 235000012754 curcumin Nutrition 0.000 claims description 8
- 239000004148 curcumin Substances 0.000 claims description 8
- 229940109262 curcumin Drugs 0.000 claims description 8
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 claims description 8
- 235000019834 papain Nutrition 0.000 claims description 8
- 229940055729 papain Drugs 0.000 claims description 8
- 102000008186 Collagen Human genes 0.000 claims description 6
- 108010035532 Collagen Proteins 0.000 claims description 6
- 229920001202 Inulin Polymers 0.000 claims description 6
- 102000004407 Lactalbumin Human genes 0.000 claims description 6
- 108090000942 Lactalbumin Proteins 0.000 claims description 6
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 6
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims description 6
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims description 6
- 235000021014 blueberries Nutrition 0.000 claims description 6
- 235000021323 fish oil Nutrition 0.000 claims description 6
- 229930182494 ginsenoside Natural products 0.000 claims description 6
- 229940089161 ginsenoside Drugs 0.000 claims description 6
- 229940029339 inulin Drugs 0.000 claims description 6
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 6
- 235000019359 magnesium stearate Nutrition 0.000 claims description 6
- 235000013336 milk Nutrition 0.000 claims description 6
- 239000008267 milk Substances 0.000 claims description 6
- 210000004080 milk Anatomy 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 239000004006 olive oil Substances 0.000 claims description 6
- 235000008390 olive oil Nutrition 0.000 claims description 6
- 235000019100 piperine Nutrition 0.000 claims description 6
- MXXWOMGUGJBKIW-YPCIICBESA-N piperine Chemical compound C=1C=C2OCOC2=CC=1/C=C/C=C/C(=O)N1CCCCC1 MXXWOMGUGJBKIW-YPCIICBESA-N 0.000 claims description 6
- 229940075559 piperine Drugs 0.000 claims description 6
- WVWHRXVVAYXKDE-UHFFFAOYSA-N piperine Natural products O=C(C=CC=Cc1ccc2OCOc2c1)C3CCCCN3 WVWHRXVVAYXKDE-UHFFFAOYSA-N 0.000 claims description 6
- 238000012372 quality testing Methods 0.000 claims description 6
- 239000001397 quillaja saponaria molina bark Substances 0.000 claims description 6
- 229930182490 saponin Natural products 0.000 claims description 6
- 150000007949 saponins Chemical class 0.000 claims description 6
- 235000020254 sheep milk Nutrition 0.000 claims description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims description 6
- 238000005303 weighing Methods 0.000 claims description 6
- 235000021241 α-lactalbumin Nutrition 0.000 claims description 6
- 241000168525 Haematococcus Species 0.000 claims description 5
- 229910052711 selenium Inorganic materials 0.000 claims description 5
- 240000000851 Vaccinium corymbosum Species 0.000 claims description 4
- 210000003022 colostrum Anatomy 0.000 claims description 3
- 235000021277 colostrum Nutrition 0.000 claims description 3
- 235000018102 proteins Nutrition 0.000 claims description 3
- 102000004169 proteins and genes Human genes 0.000 claims description 3
- 108090000623 proteins and genes Proteins 0.000 claims description 3
- 239000003513 alkali Substances 0.000 claims description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims 1
- 239000011669 selenium Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 31
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 12
- 235000013305 food Nutrition 0.000 abstract description 12
- 230000003078 antioxidant effect Effects 0.000 abstract description 11
- 239000003963 antioxidant agent Substances 0.000 abstract description 7
- 235000006708 antioxidants Nutrition 0.000 abstract description 7
- 235000016709 nutrition Nutrition 0.000 abstract description 7
- 230000008901 benefit Effects 0.000 abstract description 6
- 230000004060 metabolic process Effects 0.000 abstract description 6
- 230000035764 nutrition Effects 0.000 abstract description 6
- 238000004519 manufacturing process Methods 0.000 abstract description 5
- 230000000295 complement effect Effects 0.000 abstract description 4
- 230000002829 reductive effect Effects 0.000 abstract description 4
- 230000002195 synergetic effect Effects 0.000 abstract description 4
- 208000029549 Muscle injury Diseases 0.000 abstract description 3
- 208000000112 Myalgia Diseases 0.000 abstract description 3
- 238000011084 recovery Methods 0.000 abstract description 3
- 238000002560 therapeutic procedure Methods 0.000 abstract description 3
- 240000004371 Panax ginseng Species 0.000 description 33
- 208000002193 Pain Diseases 0.000 description 19
- 230000036407 pain Effects 0.000 description 19
- 239000000047 product Substances 0.000 description 16
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 12
- 206010061218 Inflammation Diseases 0.000 description 11
- 201000010099 disease Diseases 0.000 description 11
- 230000004054 inflammatory process Effects 0.000 description 11
- 230000012010 growth Effects 0.000 description 9
- 206010003246 arthritis Diseases 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 230000036039 immunity Effects 0.000 description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- 208000012659 Joint disease Diseases 0.000 description 6
- 206010030113 Oedema Diseases 0.000 description 6
- 210000000988 bone and bone Anatomy 0.000 description 6
- 239000006041 probiotic Substances 0.000 description 6
- 235000018291 probiotics Nutrition 0.000 description 6
- 230000008030 elimination Effects 0.000 description 5
- 238000003379 elimination reaction Methods 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 230000002757 inflammatory effect Effects 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 230000004224 protection Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 244000163122 Curcuma domestica Species 0.000 description 4
- 235000003392 Curcuma domestica Nutrition 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 235000003373 curcuma longa Nutrition 0.000 description 4
- 238000000354 decomposition reaction Methods 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 210000000629 knee joint Anatomy 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 201000008482 osteoarthritis Diseases 0.000 description 4
- -1 oxygen radical Chemical class 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 235000013976 turmeric Nutrition 0.000 description 4
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 3
- 102000009123 Fibrin Human genes 0.000 description 3
- 108010073385 Fibrin Proteins 0.000 description 3
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 3
- 108090001005 Interleukin-6 Proteins 0.000 description 3
- 102000004889 Interleukin-6 Human genes 0.000 description 3
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 3
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000001741 anti-phlogistic effect Effects 0.000 description 3
- 210000001188 articular cartilage Anatomy 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 235000013325 dietary fiber Nutrition 0.000 description 3
- 235000021196 dietary intervention Nutrition 0.000 description 3
- 235000015872 dietary supplement Nutrition 0.000 description 3
- 230000008034 disappearance Effects 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 229950003499 fibrin Drugs 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 230000008855 peristalsis Effects 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 150000005846 sugar alcohols Chemical class 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- WIGIZIANZCJQQY-UHFFFAOYSA-N 4-ethyl-3-methyl-N-[2-[4-[[[(4-methylcyclohexyl)amino]-oxomethyl]sulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide Chemical compound O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCC(C)CC2)C=C1 WIGIZIANZCJQQY-UHFFFAOYSA-N 0.000 description 2
- ZGXJTSGNIOSYLO-UHFFFAOYSA-N 88755TAZ87 Chemical compound NCC(=O)CCC(O)=O ZGXJTSGNIOSYLO-UHFFFAOYSA-N 0.000 description 2
- 244000298715 Actinidia chinensis Species 0.000 description 2
- 235000009434 Actinidia chinensis Nutrition 0.000 description 2
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 2
- 244000099147 Ananas comosus Species 0.000 description 2
- 235000007119 Ananas comosus Nutrition 0.000 description 2
- 244000189799 Asimina triloba Species 0.000 description 2
- 235000006264 Asimina triloba Nutrition 0.000 description 2
- 241000186000 Bifidobacterium Species 0.000 description 2
- 208000020084 Bone disease Diseases 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 235000009467 Carica papaya Nutrition 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 102000003777 Interleukin-1 beta Human genes 0.000 description 2
- 108090000193 Interleukin-1 beta Proteins 0.000 description 2
- 206010060820 Joint injury Diseases 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 244000077233 Vaccinium uliginosum Species 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 229930014669 anthocyanidin Natural products 0.000 description 2
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 2
- 235000008758 anthocyanidins Nutrition 0.000 description 2
- 230000002924 anti-infective effect Effects 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 230000002917 arthritic effect Effects 0.000 description 2
- 235000021028 berry Nutrition 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 235000021466 carotenoid Nutrition 0.000 description 2
- 150000001747 carotenoids Chemical class 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 230000007717 exclusion Effects 0.000 description 2
- 102000005525 fibrillarin Human genes 0.000 description 2
- 108020002231 fibrillarin Proteins 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 150000002213 flavones Chemical class 0.000 description 2
- 235000013350 formula milk Nutrition 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 210000004394 hip joint Anatomy 0.000 description 2
- 230000006450 immune cell response Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000031891 intestinal absorption Effects 0.000 description 2
- 230000007413 intestinal health Effects 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 229940118199 levulan Drugs 0.000 description 2
- 210000003041 ligament Anatomy 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 210000002997 osteoclast Anatomy 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 150000003180 prostaglandins Chemical class 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 208000037259 Amyloid Plaque Diseases 0.000 description 1
- 241001421185 Anomis Species 0.000 description 1
- 206010006811 Bursitis Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000905957 Channa melasoma Species 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 108010002352 Interleukin-1 Proteins 0.000 description 1
- 102000000589 Interleukin-1 Human genes 0.000 description 1
- 206010072970 Meniscus injury Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 241000590428 Panacea Species 0.000 description 1
- 206010036618 Premenstrual syndrome Diseases 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000005400 Synovial Cyst Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000001749 antrachitic effect Effects 0.000 description 1
- 210000000544 articulatio talocruralis Anatomy 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000010923 batch production Methods 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000002449 bone cell Anatomy 0.000 description 1
- 230000008468 bone growth Effects 0.000 description 1
- 230000004097 bone metabolism Effects 0.000 description 1
- 230000005961 cardioprotection Effects 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 210000003321 cartilage cell Anatomy 0.000 description 1
- 230000008414 cartilage metabolism Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 210000000963 osteoblast Anatomy 0.000 description 1
- 210000004409 osteocyte Anatomy 0.000 description 1
- 210000004417 patella Anatomy 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 208000005528 popliteal cyst Diseases 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 230000009758 senescence Effects 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 210000001179 synovial fluid Anatomy 0.000 description 1
- 201000004595 synovitis Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/364—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/364—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
- A23G3/366—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing microorganisms, enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/364—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
- A23G3/368—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing vitamins, antibiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/40—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds characterised by the fats used
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/42—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds characterised by the carbohydrates used, e.g. polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/44—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/46—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing dairy products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/48—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明公开了一种维护关节和缔结组织健康的雨生红球藻虾青素压片糖果,包括以下质量百分比含量的原料:虾青素15~30%、异麦芽酮糖醇5~20%、初乳碱性蛋白10~20%、人参0.5~2%、微晶纤维素30~47%、维生素D 0.5~1%和维生素C 0.5~1%。本发明将抗氧化物质虾青素和人参与异麦芽酮糖醇、初乳碱性蛋白、微晶纤维素、维生素D和维生素C按一定的比例结合,发挥其互补和协同作用,抗氧化效果较好,既能清除体内自由基,消炎、抗炎,提高关节灵活度,又能强化需氧代谢,减少肌肉疼痛,改善耐力;减少肌肉损伤,缩短恢复时间;具有产品口感好、质量稳定、营养丰富、食疗效果显著、便于携带、制备方法简单、易于工厂化生产的优点。
Description
技术领域
本发明属于食品生产技术领域,具体涉及一种维护关节和缔结组织健康的雨生红球藻虾青素压片糖果及其制备方法。
背景技术
我国骨关节炎患者超过人口总数的10%,多达1亿以上,且发病率随年龄增长而增加。骨科疾病的发病趋势不容乐观,1990~2010年20年间膝关节炎发病率增长为45%,致残率位居全球第二位,占21.3%;据推算,到2020年我国骨科慢病产生的治疗费用将增至850亿;到2050年将达18000亿。关节疾病临床表现为肿胀、疼痛、僵直、增生、患者行动自由受限、甚至造成残疾,还可累及指关节、髋关节等,严重影响人类的生活质量和寿命。危害人类的关节问题主要有骨性关节炎、类风湿性关节炎、痛风性关节炎和骨质疏松症等。作为全身活动最频繁的膝关节是全身发病率最高的关节,而且正常人到了30岁之后会出现软骨组织中营养物质下降,出现不同程度的关节问题,主要表现为疼痛、肿胀、压痛、活动受限、活动时有摩擦音,有时甚至绞锁。常见的膝关节疾病有膝关节骨性关节炎、半月板损伤、髌骨软化症、髌前滑囊炎、滑膜炎、骨质增生和腘窝囊肿等。上述疾病主要是由于软骨代谢异常、软骨组织对关节保护缺失造成的。
雨生红球藻是天然虾青素含量最高的生物,在特定的情况下,雨生红球藻可以积累占其干重1%以上的虾青素,且所含虾青素的机构与养殖对象所需要的虾青素结构一是,被公认为天然虾青素最好的生物来源。是一种脂溶性类胡萝卜素,具有抗氧化性、抗肿瘤和增强免疫力等许多重要的生理和生物学功能,其抗氧化性为维生素E的500~1000倍,为胡萝卜素的10倍,是水生藻类中公认的强抗氧化剂,通过抗氧化在人体内可以抑制老年斑的形成,对视频显示终端操作员视察疲劳具有明显的改善作用,还有助于消除因时差产生的身体不适感,其效果比常用的褪黑素还要明显。所以,虾青素具有重 要的营养价值和食疗作用
目前关节疾病主要有以下治疗方式:药物治疗、手术治疗和营养干预等。药物治疗和手术治疗弧对人体健康留下后遗症,营养干预主要是指使用关节膳食补充剂,关节膳食补充剂等来调节软骨组织合成代谢和分解代谢的平衡,调节免疫反应、氧化还原反应以及消除自由基等,为滑膜液和软骨细胞外环境提供良好的条件。采用营养干预骨关节疾病获益多、副作用小、费用低,对骨关节疾病的预防和管理具有重要意义。虽然现在市场上对于关节疾病预防和治疗的保健品和食品较多,但是,市场上采用虾青素来预防和治疗关节疾病的食品较少,基本都是采用中医治疗的理念来制备的,其在一定程度上能够缓解疼痛,但是功效成分与保健功能关联性差,在营养成分和治疗疗效上都达不到理想的要求。因此,研制开发一种配方合理、携带食用方便、疗效显著、营养丰富、消炎、抗炎效果好、且安全无毒副作用的维护关节和缔结组织健康的雨生红球藻虾青素压片糖果及其制备方法是管需要的。
发明内容
为了解决背景技术中存在的问题,本发明的目的在于提供一种配方合理、携带食用方便、疗效显著、营养丰富、消炎、抗炎效果好、且安全无毒副作用的维护关节和缔结组织健康的雨生红球藻虾青素压片糖果及其制备方法。
本发明所述的维护关节和缔结组织健康的雨生红球藻虾青素压片糖果,包括以下质量百分比含量的原料: 虾青素15~30%、异麦芽酮糖醇5~20%、初乳碱性蛋白10~20%、人参(人工种植)0.5~2%、微晶纤维素30~47%、维生素D 0.5~1%和维生素C 0.5~1%。
进一步的,所述原料中还包括0.5~1%的辅料,优选地,所述辅料包括以下重量份的成分:菊粉1~20份、沙棘果粉1~10份和蓝莓干粉1~10份。
进一步的,所述原料中还包括0.01~0.05%抗炎剂和0.01~0.05%消肿剂。优选地,所述抗炎剂包括鱼油、橄榄油、姜黄素和胡椒碱中的其中一种和两种以上混合物;所述消肿剂包括菠萝蛋白酶和木瓜蛋白酶中的其中一种或两种的混合物。
进一步的,所述人参为人参茎叶总皂苷、人参总皂甙和人参粉中的其中一种。
进一步的,所述初乳性蛋白包括以下重量备份比的成分:羊乳粉20~40%、牛乳粉20~40%、胶原蛋白粉10~30%、α-乳白蛋白1~5%、初乳碱性蛋白1~5%、硬脂酸镁0.5~2%和富硒酵母1~5%。
进一步的,所述虾青素为雨生红球藻提取物。
本发明所述雨生红球藻虾青素压片糖果的制备方法包括以下步骤:
①备料:按质量百分比称称取如下原料:虾青素15~30%、异麦芽酮糖醇5~20%、初乳碱性蛋白10~20%、人参0.5~2%、微晶纤维素30~47%、维生素D 0.5~1%和维生素C 0.5~1%;
②混料:将虾青素、异麦芽酮糖醇、初乳碱性蛋白、人参、微晶纤维、维生素D和维生素C置于混料机中,在1000~1500r/min的转速下混合搅拌20~30min得到混合物;
③灭菌:将混合物置于灭菌器中,在100~120℃的温度下灭菌5~6s;
④压片:将灭菌后的混合物输入压片机中,在50~100KN的压力下进行压片,得到压片糖果;
⑤包装:将压片后的压片糖果进行质量检测,并进行紫外线消毒、包装,即可制得成品,压片糖果的质量为0.5±0.01g。
在本发明中所述各原料的功效成分及作用机理如下:
虾青素:虾青素是一种脂溶性类胡萝卜素,也是类胡萝卜素合成的最高级别产物,呈深粉红色,化学结构类似于β-胡萝卜素。虾青素是世界上最强的天然抗氧化剂之一,能有效清除细胞内的氧自由基,增强细胞再生能力,维持机体平衡和减少衰老细胞的堆积,由内而外保护细胞和DNA健康,从而保护皮肤健康,促进毛发生长,抗衰老、缓解运动疲劳、增强活力。国内外大量研究证实虾青素具有较强的抗氧化活性,在提高免疫力,预防肿瘤、心血管疾病、 糖尿病等慢性疾病的发生发展,延缓衰老等方面具有积极的促进作用。
异麦芽酮糖醇:异麦芽酮糖醇是一种功能性糖醇,是蔗糖、淀粉糖和其他糖醇的优良替代品,甜度是蔗糖的50~60%,具有低吸湿性、高稳定性、高耐受性、低热量、味甜纯正的优点。
初乳碱性蛋白:初乳碱性蛋白2009年被批准为新资源食品,具有如下特点和功能:活 性蛋白,分子量小,可直接作用于骨骼细胞,促进骨骼新陈代谢,能协调成 骨细胞和破骨细胞的活动,保持两者的动态平衡,促进骨骼生长。
人参:人参大补元气,补脾益肺,生津止渴,安神益智、主补五脏、安精神、定魂魄、止惊悸、除邪气、明目、开心、益智,久服轻身健体;乃补气之圣药能入五脏六腑;治 一切虚症,大补元气,固脱生津,主治健忘眩晕头痛阳痿早泄尿频尿急。本发明采用人参为按现行标准规范人工种植并检测合格的人参。
微晶纤维素:微晶纤维素兼具膳食纤维和稳定剂功能,同时还具有促进肠道蠕动、改善肠道菌群生态平衡,预防高血压、高血脂的功效,能够搭载更多的活性成分,并且对小肠粘膜起到保护作用,有利于提高肠道的吸收能力。
维生素D:维生素D是固醇类衍生物,具抗 佝偻病作用。
维生素C:又称L-抗坏血酸,是人体必需的营养素。
综上所述:本发明利用虾青素的抗氧化功能消除人体的自由基,利用异麦芽酮糖醇、初乳碱性蛋白和人生减缓关节损伤、气滞血瘀等问题,补充能量和营养的同时,合理的搭配微晶纤维素、维生素D和维生素C能够提高人体自身的免疫力,改善血液训话,修复肌纤维。
从上述主要原料和营养功能分析,本发明将抗氧化物质虾青素和人参与异麦芽酮糖醇、初乳碱性蛋白微晶纤维素、维生素D和维生素C按一定的比例结合,发挥其互补和协同作用,抗氧化效果较好,既能清除体内自由基,消炎、抗炎,提高关节灵活度,使行动更加顺畅,又能强化需氧代谢,减少肌肉疼痛,改善耐力;减少肌肉损伤,缩短恢复时间;促进脂肪燃烧,获得更高能量等级;还能维持剧烈运动后的关节功能、增强机体免疫力,不仅具有产品口感好、质量稳定、营养丰富、食疗效果显著、便于携带、制备方法简单、易于工厂化生产的优点,而且进一步的丰富了雨生红球藻虾青素的食品市场,非常适合关节炎患者或缓解疲劳运动的人群饮用,具有较好的推广利用价值。
具体实施方式
下面结合实施例对本发明作进一步的说明,但不以任何方式对本发明加以限制,基于本发明教导所作的任何变换或替换,均属于本发明的保护范围。
实施例1:
本实施例1所述的的维护关节和缔结组织健康的雨生红球藻虾青素压片糖果,包括以下质量百分比含量的原料: 虾青素15%、异麦芽酮糖醇20、初乳碱性蛋白20%、人参2%、微晶纤维素41%、维生素D1%和维生素C1%。本发明采用人参为按现行标准规范人工种植并检测合格的人参。
在本实施例中:所述人参为人参茎叶总皂苷、人参总皂甙和人参粉中的其中一种。
所述初乳性蛋白包括以下重量备份比的成分:羊乳粉20%、牛乳粉40%、胶原蛋白粉23%、α-乳白蛋白5%、初乳碱性蛋白5%、硬脂酸镁2%和富硒酵母5%。
所述虾青素为雨生红球藻提取物。
所述生红球藻虾青素压片糖果的制备方法包括以下步骤:
①备料:按质量百分比称称取如下原料:虾青素15%、异麦芽酮糖醇20、初乳碱性蛋白20%、人参2%、微晶纤维素41%、维生素D1%和维生素C1%;
②混料:将虾青素、异麦芽酮糖醇、初乳碱性蛋白、人参、微晶纤维、维生素D和维生素C置于混料机中,在1000r/min的转速下混合搅拌20min得到混合物;
③灭菌:将混合物置于灭菌器中,在100℃的温度下灭菌5s;
④压片:将灭菌后的混合物输入压片机中,在50KN的压力下进行压片,得到压片糖果;
⑤包装:将压片后的压片糖果进行质量检测,并进行紫外线消毒、包装,即可制得成品,压片糖果的质量为0.5g。
实施例2
本实施例2所述的维护关节和缔结组织健康的雨生红球藻虾青素压片糖果,包括以下质量百分比含量的原料: 虾青素28%、异麦芽酮糖醇5%、初乳碱性蛋白20%、人1.5%、微晶纤维素43.5%、维生素D 0.5%、维生素C1%和辅料0.5%。
在本实施中:
所述辅料包括以下重量份的成分:菊粉1份、沙棘果粉10份和蓝莓干粉10份。
菊粉又名菊糖,是一类天然果聚糖的混合物,已经被世界上许多国家批准作为食品营养补充剂。作为一种天然的可溶性膳食纤维,进入人体后不被胃和小肠吸收而直接进入大肠内,促进肠道蠕动的同时优先被双歧杆菌、乳酸菌等益生菌利用,有利于益生菌的增值;益生菌生长使肠道pH值降低,抑制有害菌的生长,从而有利于肠道健康。
沙棘果粉实中富含大量的维生素C、维生素E、β胡萝卜素、黄酮、SOD等生物活性物质和人体所需的各种氨基酸和微量元素,其Vc含量是猕猴桃的2~5倍,被称为“水果之王”,因此沙棘具有提高免疫力、健脑益智、降血压、降血脂等作用。
蓝莓干粉含有丰富的花青素,是一种清除人体内自由基有效的天然抗氧化剂,,够改善血液循环、保护视力、消除水 肿、滋润皮肤、加快了有害的胆固醇的分解和排除,保护心脏、减轻过敏发炎、改善静脉 张、增强记忆力、减缓衰老及降低中风的风险,改善缺氧、缓解经前综合症。
上述辅料与各种原料按一定的比例配合后,发挥其互补和协同作用,加强抗氧化的效果,促进骨骼的新陈代谢,促进软骨的修复。
所述人参为人参茎叶总皂苷、人参总皂甙和人参粉中的其中一种。
所述初乳性蛋白包括以下重量备份比的成分:羊乳粉30%、牛乳粉30%、胶原蛋白粉30%、α-乳白蛋白2%、初乳碱性蛋白2%、硬脂酸镁2%和富硒酵母4%。
所述虾青素为雨生红球藻提取物。
所述的生红球藻虾青素压片糖果的制备方法包括以下步骤:
①备料:按质量百分比称称取如下原料:虾虾青素28%、异麦芽酮糖醇5%、初乳碱性蛋白20%、人1.5%、微晶纤维素43.5%、维生素D 0.5%、维生素C1%和辅料0.5%;
②混料:将虾青素、异麦芽酮糖醇、初乳碱性蛋白、人参、微晶纤维、维生素D、维生素C和辅料置于混料机中,在1200r/min的转速下混合搅拌25min得到混合物;
③灭菌:将混合物置于灭菌器中,在110℃的温度下灭菌6s;
④压片:将灭菌后的混合物输入压片机中,在80KN的压力下进行压片,得到压片糖果;
⑤包装:将压片后的压片糖果进行质量检测,并进行紫外线消毒、包装,即可制得成品,压片糖果的质量为0.51g。
实施例3
本实施例3所述的维护关节和缔结组织健康的雨生红球藻虾青素压片糖果, 包括以下质量百分比含量的原料: 虾青素30%、异麦芽酮糖醇20%、初乳碱性蛋白10%、人参2%、微晶纤维素35%、维生素D 1%、维生素C 0.99%、辅料0.99%、抗炎剂0.01%和消肿剂0.01%。
在本实施例中
所述辅料包括以下重量份的成分:菊粉20份、沙棘果粉1份和蓝莓干粉1份。
菊粉又名菊糖,是一类天然果聚糖的混合物,已经被世界上许多国家批准作为食品营养补充剂。作为一种天然的可溶性膳食纤维,进入人体后不被胃和小肠吸收而直接进入大肠内,促进肠道蠕动的同时优先被双歧杆菌、乳酸菌等益生菌利用,有利于益生菌的增值;益生菌生长使肠道pH值降低,抑制有害菌的生长,从而有利于肠道健康。
沙棘果粉实中富含大量的维生素C、维生素E、β胡萝卜素、黄酮、SOD等生物活性物质和人体所需的各种氨基酸和微量元素,其Vc含量是猕猴桃的2~5倍,被称为“水果之王”,因此沙棘具有提高免疫力、健脑益智、降血压、降血脂等作用
蓝莓干粉含有丰富的花青素,是一种清除人体内自由基有效的天然抗氧化剂,,够改善血液循环、保护视力、消除水 肿、滋润皮肤、加快了有害的胆固醇的分解和排除,保护心脏、减轻过敏发炎、改善静脉 张、增强记忆力、减缓衰老及降低中风的风险,改善缺氧、缓解经前综合症。
所述抗炎剂包括鱼油、橄榄油、姜黄素和胡椒碱中的其中一种和两种以上混合物;所述消肿剂包括菠萝蛋白酶和木瓜蛋白酶中的其中一种或两种的混合物。
鱼油、橄榄油富含不饱和脂肪酸,通过调节钙的吸收、破骨细胞合成、***素合成等从而影响骨的生长代谢,抑制关节炎症反应,缓解疼痛。
姜黄是姜黄属姜科植物,主要活性成分为姜黄素,姜黄素具有抗感染、抗氧化和抗炎作用等。
胡椒碱通过抑制关节炎症过程中血清TNF-α、IL-1β、IL-6等炎症因子的表达,从而起到抑制骨关节炎的作用。
菠萝蛋白酶和木瓜蛋白酶分别从菠萝和木瓜中提取得到,菠萝蛋白酶具有消炎,抑制免疫细胞反应,促进营养物质吸收的作用;木瓜蛋白酶具有极强的分解能力,能促进纤维蛋白的水解,消除由炎症或创伤等原因所产生的纤维蛋白,使炎症消退,起到抗炎、消除水肿的作用。
本实施例在有原料的基础上,加入一定比例的辅料、抗炎剂和消肿剂,几种物质间相互作用后,从关节软骨修复、炎症信号通路的阻断和改善体液局部循环消除水肿这几个方面协同作用,有效维持关节健康。
所述人参为人参茎叶总皂苷、人参总皂甙和人参粉中的其中一种。
所述初乳性蛋白包括以下重量备份比的成分:羊乳粉35%、牛乳粉25%、胶原蛋白粉25%、α-乳白蛋白5%、初乳碱性蛋白5%、硬脂酸镁2%和富硒酵母3%。
所述虾青素为雨生红球藻提取物。
所述的生红球藻虾青素压片糖果的制备方法包括以下步骤:
①备料:按质量百分比称称取如下原料:虾青素30%、异麦芽酮糖醇20%、初乳碱性蛋白10%、人参2%、微晶纤维素35%、维生素D 1%、维生素C 0.99%、辅料0.99%、抗炎剂0.01%和消肿剂0.01%;
②混料:将虾青素、异麦芽酮糖醇、初乳碱性蛋白、人参、微晶纤维、维生素D、维生素C、辅料、抗炎剂和消肿剂置于混料机中,在1800r/min的转速下混合搅拌30min得到混合物;
③灭菌:将混合物置于灭菌器中,在115℃的温度下灭菌5s;
④压片:将灭菌后的混合物输入压片机中,在90KN的压力下进行压片,得到压片糖果;
⑤包装:将压片后的压片糖果进行质量检测,并进行紫外线消毒、包装,即可制得成品,压片糖果的质量为0.49g。
实施例4
本实施例4所述的维护关节和缔结组织健康的雨生红球藻虾青素压片糖果,包括以下质量百分比含量的原料: 虾青素19.5%、异麦芽酮糖醇20%、初乳碱性蛋白10%、人参1.5%、微晶纤维素47%、维生素D 0.95%和维生素C0.95%、抗炎剂0.05%和消肿剂0.05%。
在本实施中:
所述抗炎剂包括鱼油、橄榄油、姜黄素和胡椒碱中的其中一种和两种以上混合物;所述消肿剂包括菠萝蛋白酶和木瓜蛋白酶中的其中一种或两种的混合物。
鱼油、橄榄油富含不饱和脂肪酸,通过调节钙的吸收、破骨细胞合成、***素合成等从而影响骨的生长代谢,抑制关节炎症反应,缓解疼痛。
姜黄是姜黄属姜科植物,主要活性成分为姜黄素,姜黄素具有抗感染、抗氧化和抗炎作用等。
胡椒碱通过抑制关节炎症过程中血清TNF-α、IL-1β、IL-6等炎症因子的表达,从而起到抑制骨关节炎的作用。
菠萝蛋白酶和木瓜蛋白酶分别从菠萝和木瓜中提取得到,菠萝蛋白酶具有消炎,抑制免疫细胞反应,促进营养物质吸收的作用;木瓜蛋白酶具有极强的分解能力,能促进纤维蛋白的水解,消除由炎症或创伤等原因所产生的纤维蛋白,使炎症消退,起到抗炎、消除水肿的作用。
消炎剂能够阻断TNF-α、 IL-1、IL-6等细胞因子及相关炎症信号通路,也可以通过抑制活性氧的产生,清除自由基和过氧化物而发挥抗氧化作用;消肿剂能够加强体内纤维蛋白的水解作用,将阻塞于组织的纤维蛋白及血凝块溶解,从而改善体液的局部循环,导致炎症和水肿的消除,与各原料协同作用后能够达到修复关节软骨、消除炎症反应、消除关节肿胀、强健韧带、增长肌肉的效果。
所述人参为人参茎叶总皂苷、人参总皂甙和人参粉中的其中一种。
所述初乳性蛋白包括以下重量备份比的成分:羊乳粉40%、牛乳粉35%、胶原蛋白粉20%、α-乳白蛋白1%、初乳碱性蛋白1%、硬脂酸镁1.5%和富硒酵母1.5%。
所述虾青素为雨生红球藻提取物。
所述生红球藻虾青素压片糖果的制备方法包括以下步骤:
①备料:按质量百分比称称取如下原料:虾青素19.5%、异麦芽酮糖醇20%、初乳碱性蛋白10%、人参1.5%、微晶纤维素47%、维生素D 0.95%和维生素C0.95%、抗炎剂0.05%和消肿剂0.05%;
②混料:将虾青素、异麦芽酮糖醇、初乳碱性蛋白、人参、微晶纤维、维生素D、维生素C、抗炎剂和消肿剂置于混料机中,在1500r/min的转速下混合搅拌30min得到混合物;
③灭菌:将混合物置于灭菌器中,在120℃的温度下灭菌6s;
④压片:将灭菌后的混合物输入压片机中,在100KN的压力下进行压片,得到压片糖果;
⑤包装:将压片后的压片糖果进行质量检测,并进行紫外线消毒、包装,即可制得成品,压片糖果的质量为0.5g。
本实施例1~4将抗氧化物质虾青素和人参与异麦芽酮糖醇、初乳碱性蛋白微晶纤维素、维生素D和维生素C按一定的比例结合,发挥其互补和协同作用,抗氧化效果较好,且能同时发挥多种物质的功效,既能清除体内自由基,消炎、抗炎,提高关节灵活度,使行动更加顺畅,又能强化需氧代谢,减少肌肉疼痛,改善耐力;减少肌肉损伤,缩短恢复时间;促进脂肪燃烧,获得更高能量等级;还能维持剧烈运动后的关节功能、增强机体免疫力,不仅具有产品口感好、质量稳定、营养丰富、食疗效果显著、便于携带、制备方法简单、易于工厂化生产的优点,而且进一步的丰富了雨生红球藻虾青素的食品市场,非常适合关节炎患者或缓解疲劳运动的人群饮用。
为了检验本发明舍得产品对维护关节和***的疗效,进行了如下试验:
一、饮用对象
选取年龄在经常跑步或者是各种运动人群中的有关节炎或者膝关节、踝关节、髋关节疼痛且且痛程度近似的100名的实验者;随机分成4组,每组20人,分别为第一组、第二组、第三组和第四组;
二、服用方法
第一组口服实施例1的产品,第二组口服实施例2的产品,第三组口服实施例3的产品,第四组口服实施例4的产品,每次口服2片,一日3次(早上、中午、晚上各一次),服用10天,10天后进行痛感测试,服用期间,中止运动,劳作等高负荷活动,但不进行休假静养,照常进行普通工作学习等生活活动。
三、测试结果的记录如下:
在第一组中:有15人疼痛感消失,有9人有轻微感疼痛,有1人疼痛有缓解;
在第二组中:有20人疼痛感消失,有5人有轻微感疼痛;
在第三组中:全部的25人疼痛感消;
在第一组中:有21人疼痛感消失,有4人有轻微感疼痛;
从上述的从测试结果可以看出,100名实验者中有81人的疼痛症状已经完全消失,有18人只有轻微的疼痛感,有1人的疼痛感有所缓解,其减弱或治愈的有效率达到了99%以上,实验3个月后续跟踪,痊愈对象中持续服用60名恢复训练后无再发。
上述实验证实本产品对有助于解关节不适,均衡营养,达到修复关节软骨、消除炎症反应、消除关节肿胀、强健韧带、增长肌肉的效果,长期服用能保护关节组织,抑制炎症,促进关节损伤的修复。
Claims (9)
1.一种维护关节和缔结组织健康的雨生红球藻虾青素压片糖果,其特征在于:包括以下质量百分比含量的原料: 虾青素15~30%、异麦芽酮糖醇5~20%、初乳碱性蛋白10~20%、人参0.5~2%、微晶纤维素30~47%、维生素D 0.5~1%和维生素C 0.5~1%。
2.根据权利要求1所述的一种维护关节和缔结组织健康的雨生红球藻虾青素压片糖果,其特征在于:所述原料中还包括0.5~1%的辅料。
3.根据权利要求2所述的一种维护关节和缔结组织健康的雨生红球藻虾青素压片糖果,其特征在于:所述辅料包括以下重量份的成分:菊粉1~20份、沙棘果粉1~10份和蓝莓干粉1~10份。
4.根据权利要求1所述的一种维护关节和缔结组织健康的雨生红球藻虾青素压片糖果,其特征在于:所述原料中还包括0.01~0.05%抗炎剂和0.01~0.05%消肿剂。
5.根据权利要求4所述的一种维护关节和缔结组织健康的雨生红球藻虾青素压片糖果,其特征在于:所述抗炎剂包括鱼油、橄榄油、姜黄素和胡椒碱中的其中一种和两种以上混合物;所述消肿剂包括菠萝蛋白酶和木瓜蛋白酶中的其中一种或两种的混合物。
6.根据权利要求1所述的一种维护关节和缔结组织健康的雨生红球藻虾青素压片糖果,其特征在于:所述人参为人参茎叶总皂苷、人参总皂甙和人参粉中的其中一种。
7.根据权利要求1所述的一种维护关节和缔结组织健康的雨生红球藻虾青素压片糖果,其特征在于:所述初乳性蛋白包括以下重量备份比的成分:羊乳粉20~40%、牛乳粉20~40%、胶原蛋白粉10~30%、α-乳白蛋白1~5%、初乳碱性蛋白1~5%、硬脂酸镁0.5~2%和富硒酵母1~5%。
8.根据权利要求1所述的一种维护关节和缔结组织健康的雨生红球藻虾青素压片糖果,其特征在于:所述虾青素为雨生红球藻提取物。
9.根据权利要求1所述的一种维护关节和缔结组织健康的雨生红球藻虾青素压片糖果,其特征在于:生红球藻虾青素压片糖果的制备方法包括以下步骤:
①备料:按质量百分比称称取如下原料:虾青素15~30%、异麦芽酮糖醇5~20%、初乳碱性蛋白10~20%、人参0.5~2%、微晶纤维素30~47%、维生素D 0.5~1%和维生素C 0.5~1%;
②混料:将虾青素、异麦芽酮糖醇、初乳碱性蛋白、人参、微晶纤维、维生素D和维生素C置于混料机中,在1000~1500r/min的转速下混合搅拌20~30min得到混合物;
③灭菌:将混合物置于灭菌器中,在100~120℃的温度下灭菌5~6s;
④压片:将灭菌后的混合物输入压片机中,在50~100KN的压力下进行压片,得到压片糖果;
⑤包装:将压片后的压片糖果进行质量检测,并进行紫外线消毒、包装,即可制得成品,压片糖果的质量为0.5±0.01g。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910045882.6A CN109601680A (zh) | 2019-01-17 | 2019-01-17 | 一种维护关节和缔结组织健康的雨生红球藻虾青素压片糖果及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910045882.6A CN109601680A (zh) | 2019-01-17 | 2019-01-17 | 一种维护关节和缔结组织健康的雨生红球藻虾青素压片糖果及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109601680A true CN109601680A (zh) | 2019-04-12 |
Family
ID=66019812
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910045882.6A Pending CN109601680A (zh) | 2019-01-17 | 2019-01-17 | 一种维护关节和缔结组织健康的雨生红球藻虾青素压片糖果及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109601680A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110236147A (zh) * | 2019-05-08 | 2019-09-17 | 深圳市淳睿科技发展有限公司 | 保健品组合物、其制备方法及其应用 |
CN113925166A (zh) * | 2020-12-14 | 2022-01-14 | 常州市第二人民医院 | 一种虾青素组合物及其制备方法 |
CN114431328A (zh) * | 2022-02-11 | 2022-05-06 | 青岛海智源生命科技有限公司 | 一种可改善女性痛经症状的复合压片糖果 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130287756A1 (en) * | 2009-07-23 | 2013-10-31 | U.S. Nutraceuticals, Llc D/B/A Valensa International | Composition and method to alleviate joint pain |
CN104770636A (zh) * | 2015-03-03 | 2015-07-15 | 青岛森淼实业有限公司 | 含虾青素和益生元的营养补充剂及其制备的压片糖果 |
CN106689618A (zh) * | 2016-11-21 | 2017-05-24 | 云南爱尔康生物技术有限公司 | 一种虾青素压片糖果制作方法 |
CN107259046A (zh) * | 2017-06-07 | 2017-10-20 | 陕西必康制药集团控股有限公司 | 具有抗氧化功能的雨生红球藻压片糖果及其制备方法 |
CN108741099A (zh) * | 2018-06-11 | 2018-11-06 | 广州尚天诚品生物科技有限公司 | 一种有助于关节舒适的营养组合物及其制备方法和应用 |
-
2019
- 2019-01-17 CN CN201910045882.6A patent/CN109601680A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130287756A1 (en) * | 2009-07-23 | 2013-10-31 | U.S. Nutraceuticals, Llc D/B/A Valensa International | Composition and method to alleviate joint pain |
CN104770636A (zh) * | 2015-03-03 | 2015-07-15 | 青岛森淼实业有限公司 | 含虾青素和益生元的营养补充剂及其制备的压片糖果 |
CN106689618A (zh) * | 2016-11-21 | 2017-05-24 | 云南爱尔康生物技术有限公司 | 一种虾青素压片糖果制作方法 |
CN107259046A (zh) * | 2017-06-07 | 2017-10-20 | 陕西必康制药集团控股有限公司 | 具有抗氧化功能的雨生红球藻压片糖果及其制备方法 |
CN108741099A (zh) * | 2018-06-11 | 2018-11-06 | 广州尚天诚品生物科技有限公司 | 一种有助于关节舒适的营养组合物及其制备方法和应用 |
Non-Patent Citations (1)
Title |
---|
张雅利,等: "《营养与健康》", 31 December 2018, 西安交通大学出版社 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110236147A (zh) * | 2019-05-08 | 2019-09-17 | 深圳市淳睿科技发展有限公司 | 保健品组合物、其制备方法及其应用 |
CN113925166A (zh) * | 2020-12-14 | 2022-01-14 | 常州市第二人民医院 | 一种虾青素组合物及其制备方法 |
CN114431328A (zh) * | 2022-02-11 | 2022-05-06 | 青岛海智源生命科技有限公司 | 一种可改善女性痛经症状的复合压片糖果 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109123643A (zh) | 一种谷物代餐球的制备方法 | |
CN105285952A (zh) | 一种营养均衡的代餐粉及其制备方法 | |
CN109601680A (zh) | 一种维护关节和缔结组织健康的雨生红球藻虾青素压片糖果及其制备方法 | |
CN108719984B (zh) | 一种针对痛风人群的代餐营养棒及其制备方法 | |
Kumar et al. | Green blood therapy of wheat grass-Nature’s finest medicine’-A literature review | |
CN105124347A (zh) | 一种辣木降血糖组合物及其制备方法 | |
CN115736142A (zh) | 一种益生元西梅纤维果饮的配方及制备工艺 | |
CN106418501A (zh) | 一种具有减肥功能的保健食品 | |
CN102090563A (zh) | 一种纾压和舒眠的保健食品及其制备方法 | |
CN105146609A (zh) | 一种降脂润肠醋饮及其制备方法 | |
CN110583780A (zh) | 一种可以预防和降低高血压和高尿酸的固体饮料 | |
CN105943958A (zh) | 一种治疗痛风的桦褐孔菌复合固体颗粒及其制备方法 | |
CN111184214A (zh) | 酵素胶原蛋白杂粮果蔬即食代餐粥及其制作方法 | |
CN103238889A (zh) | 一种抗疲劳苹果醋保健饮料及其制备方法 | |
CN105707378A (zh) | 黑青稞瘦身咖啡 | |
CN106174286A (zh) | 高级金枸杞营养果酱 | |
KR20080090808A (ko) | 피부미용을 위한 건강보조식품의 조성물 | |
CA2607267A1 (en) | Health food and pharmaceutical composition for amelioration of disease induced by metabolic disorder in cartilage | |
KR100977849B1 (ko) | 유산균이 함유된 김치를 포함하는 녹즙 조성물 | |
CN1943695A (zh) | 一种甲鱼制剂及其生产工艺 | |
CN115553406A (zh) | 抑制脂肪和糖类物质吸收的减肥组合物饮料及制备方法 | |
CN114617267A (zh) | 一种强化型复合骨肽及其制备方法与应用 | |
CN101224005B (zh) | 一种具有全营养补充功效的营养片剂及其生产方法 | |
KR102480311B1 (ko) | 체질 맞춤형의 학습 능력 증진용 건강 기능성 식품 조성물 제조방법 | |
CN100506085C (zh) | 一种能够提高产妇免疫力的红糖保健品 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190412 |
|
RJ01 | Rejection of invention patent application after publication |